HomeSYRE • NASDAQ
add
Spyre Therapeutics Inc
Previous close
$43.21
Day range
$42.26 - $45.76
Year range
$10.91 - $45.76
Market cap
3.47B USD
Avg Volume
676.07K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.53M | 16.37% |
Net income | -62.53M | -11.07% |
Net profit margin | — | — |
Earnings per share | -0.74 | 8.64% |
EBITDA | — | — |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 756.53M | 25.44% |
Total assets | 777.78M | 27.82% |
Total liabilities | 62.54M | -31.03% |
Total equity | 715.24M | — |
Shares outstanding | 78.54M | — |
Price to book | 6.04 | — |
Return on assets | -22.29% | — |
Return on capital | -24.43% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -62.53M | -11.07% |
Cash from operations | -44.58M | -19.84% |
Cash from investing | -247.41M | -45.07% |
Cash from financing | 312.81M | 38.66% |
Net change in cash | 20.82M | 16.71% |
Free cash flow | -9.35M | 69.91% |
About
Founded
Jan 1, 2013
Headquarters
Website
Employees
102
